Related references
Note: Only part of the references are listed.A prospective study on vulvovaginal candidiasis: multicentre molecular epidemiology of pathogenic yeasts in China
N. Song et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)
CDC Sexually Transmitted Infections Treatment Guidelines, 2021
Aniruddha Hazra et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Possible misdiagnosis, inappropriate empiric treatment, and opportunities for increased diagnostic testing for patients with vulvovaginal candidiasis-United States, 2018
Kaitlin Benedict et al.
PLOS ONE (2022)
Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020
Kaitlin Benedict et al.
BMC WOMENS HEALTH (2022)
Diagnosis and Treatment of Vaginal Discharge Syndromes in Community Practice Settings
Sharon L. Hillier et al.
CLINICAL INFECTIOUS DISEASES (2021)
Sexually Transmitted Infections Treatment Guidelines, 2021
Kimberly A. Workowski et al.
MMWR Recommendations and Reports (2021)
Molecular Epidemiology, Antifungal Susceptibility, and Virulence Evaluation of Candida Isolates Causing Invasive Infection in a Tertiary Care Teaching Hospital
Junzhu Chen et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Ibrexafungerp: A novel oral glucan synthase inhibitor
M. R. Davis et al.
MEDICAL MYCOLOGY (2020)
British Association for Sexual Health and HIV national guideline for the management of vulvovaginal candidiasis (2019)
Cara Saxon et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2020)
Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes
Junko Yano et al.
BMC WOMENS HEALTH (2019)
Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis
Sofia Maraki et al.
MYCOSES (2019)
Global burden of recurrent vulvovaginal candidiasis: a systematic review
David W. Denning et al.
LANCET INFECTIOUS DISEASES (2018)
Reduced Antifungal Susceptibility of Vulvovaginal Candida Species at Normal Vaginal pH Levels: Clinical Implications
Mark Spitzer et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2018)
An Update on the Roles of Non-albicans Candida Species in Vulvovaginitis
Olufunmilola Makanjuola et al.
JOURNAL OF FUNGI (2018)
Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates
Tchana Martinez Brandolt et al.
BRAZILIAN JOURNAL OF MICROBIOLOGY (2017)
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2016)
Distribution and Drug Susceptibility of Candida spp. Associated With Female Genital Tract Infection, Chongqing, China
Xiaodong Luo et al.
JUNDISHAPUR JOURNAL OF MICROBIOLOGY (2016)
Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis
Masahito Nagashima et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2016)
Species spectrum and antifungal susceptibility profile of vaginal isolates of Candida in Kuwait
W. Alfouzan et al.
JOURNAL DE MYCOLOGIE MEDICALE (2015)
Molecular identification and antifungal susceptibility of 186 Candida isolates from vulvovaginal candidiasis in southern China
Xiao-Yu Shi et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2015)
Vulvovaginitis: Screening for and Management of Trichomoniasis, Vulvovaginal Candidiasis, and Bacterial Vaginosis
Julie van Schalkwyk et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2015)
Species distribution and susceptibility of Candida isolates from patient with Vulvovaginal candidiasis in Southern China from 2003 to 2012
X. P. Liu et al.
JOURNAL DE MYCOLOGIE MEDICALE (2014)
In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents
F. Choukri et al.
JOURNAL DE MYCOLOGIE MEDICALE (2014)
Aetiologies and contributing factors of vulvovaginal candidiasis in Abidjan (Cote d'Ivoire)
A. Konate et al.
JOURNAL DE MYCOLOGIE MEDICALE (2014)
Epidemiology and Antifungal Susceptibilities of Yeasts Causing Vulvovaginitis in a Teaching Hospital
Soledad Gamarra et al.
MYCOPATHOLOGIA (2014)
Candida vaginitis in non-pregnant patients: A study of antifungal susceptibility testing and virulence factors
A. Kalkanci et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2013)
VULVOVAGINAL CANDIDIASIS IN MATO GROSSO, BRAZIL: PREGNANCY STATUS, CAUSATIVE SPECIES AND DRUGS TESTS
Luciana Basili Dias et al.
BRAZILIAN JOURNAL OF MICROBIOLOGY (2011)
Antifungal Activity of Brazilian Propolis Microparticles against Yeasts Isolated from Vulvovaginal Candidiasis
Kelen Fatima Dalben Dota et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2011)
In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis
S. R. Fan et al.
MYCOSES (2011)
Recurrent vulvovaginal candidosis: focus on the vulva
Florian C. Beikert et al.
MYCOSES (2011)
Correlation between Azole Susceptibilities, Genotypes, and ERG11 Mutations in Candida albicans Isolates Associated with Vulvovaginal Candidiasis in China
Shu-Hua Ge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Use of CHROMagar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited settings
Sayyada Ghufrana Nadeem et al.
LIBYAN JOURNAL OF MEDICINE (2010)
Prevalence and management of non-albicans vaginal candidiasis
Nalin Hetticarachchi et al.
SEXUALLY TRANSMITTED INFECTIONS (2010)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Survey of vaginal-flora candida species isolates from women of different age groups by use of species-specific PCR detection
John-Paul Vermitsky et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Treatment of non-albicans Candida vaginitis with amphotericin B vaginal suppositories
AJ Phillips
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases
SS Richter et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Identification of yeasts in public hospital primary care patients with or without clinical vaginitis
H Erdem et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2003)
Combined topical flucytosine and amphotericin B for refractory vaginal Candida glabrata infections
DJ White et al.
SEXUALLY TRANSMITTED INFECTIONS (2001)
Share Paper
